Verrica Pharmaceuticals Inc. ( VRCA) - Stock Earnings
VRCA Upcoming earnings
Estimated EPS and revenue columns are available to paid members.
| Date | EPS (actual / est.) | Revenue low (est.) | Revenue (actual / est.) | Revenue high (est.) |
|---|---|---|---|---|
| Nov. 13, 2026, midnight | — / — | — | — / — | — |
VRCA Quarterly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2025Q4 | -8.1 million USD | 5.1 million USD |
| 2026Q1 | -9.7 million USD | 5.0 million USD |
| 2026Q2 | -13.2 million USD | 5.9 million USD |
| 2026Q4 Est. | — | — |
| 2027Q1 Est. | — | — |
| 2027Q2 Est. | — | — |
VRCA Yearly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -67.0 million USD | 5.1 million USD |
| 2024 | -76.6 million USD | 7.6 million USD |
| 2025 | -17.9 million USD | 35.6 million USD |
| 2026 Est. | — | — |
VRCA
Price: $3.60
52 week price:
Earnings Per Share: -1.69 USD
Exchange: NGM
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 337100
Market Capitalization: 74.0 million